"
Team:SupBiotech-Paris
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 14: | Line 14: | ||
<br> | <br> | ||
See you guys!<br></font> | See you guys!<br></font> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
<br> | <br> | ||
<br> | <br> | ||
Revision as of 22:32, 18 August 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Welcome Foreigner,
Our project is a vectorization system, we chose mycobacterium, a microorganism with high tropism for specific tissues, and a synthetic Lambda phage able to infect eukaryotic cells.First, to target tissue, we use mycobacterium, and then to target the cell population, we use the synthetic lambda phage.
See you guys!
